Peterson Kristine 4
4 · ArriVent BioPharma, Inc. · Filed Apr 23, 2024
Insider Transaction Report
Form 4
Peterson Kristine
Director
Transactions
- Award
Stock Option (right to buy)
2024-04-22+28,587→ 28,587 totalExercise: $15.90Exp: 2034-04-21→ Common Stock (28,587 underlying)
Footnotes (1)
- [F1]These options vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date.